Evolv Technologies is a Buy for me, driven by strong SaaS adoption, expanding recurring revenue, and clear market relevance in education and healthcare. Financials show robust ARR growth, improving margins, and disciplined cost control, with a strong balance sheet and no long-term debt. Key growth drivers include rising demand in schools, hospitals, and public venues, plus new products and a Certified Pre-Owned program to broaden market reach.
Evolv Technologies Holdings, Inc. (NASDAQ:EVLV ) Q1 2025 Earnings Conference Call May 20, 2025 4:30 PM ET Company Participants Brian Norris - SVP of Finance and IR John Kedzierski - President and CEO Chris Kutsor - CFO Conference Call Participants Jeremy Hamblin - Craig Hallum Michael Latimore - Northland Capital Markets Eric Martinuzzi - Lake Street Capital Markets Brett Knoblauch - Cantor Fitzgerald Operator Good afternoon and welcome to the Evolv Technology First Quarter Earnings Result Conference Call. All participants are in a listen-only mode.
Evolv: Huge Upside Potential From A Life-Saving Technology
NEW YORK, NY / ACCESSWIRE / December 31, 2024 / If you suffered a loss on your Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Evolv Technologies shares are riding on strategic partnerships and an expanding footprint. Yet, macroeconomic challenges are concerning.
NEW YORK, NY / ACCESSWIRE / December 31, 2024 / If you suffered a loss on your Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 31, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Evolv Technologies Holdings, Inc. ("Evolv" or the "Company") (NASDAQ:EVLV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, NY / ACCESSWIRE / December 31, 2024 / If you suffered a loss on your Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK CITY, NY / ACCESSWIRE / December 31, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Evolv Technologies Holdings, Inc. ("Evolv Technologies" or "the Company") (NASDAQ:EVLV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Evolv Technologies securities between August 19, 2022 and October 30, 2024 inclusive (the "Class Period").
NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 30, 2024 / If you suffered a loss on your Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.